In this context, Fas activation on tumor cells can induce the NF-κB, ERK1/2-MAPK, and PI3K/Akt pathways, thus promoting their migration and acquisition of EMT and CSC-like properties [17,18,19,20,26]. The gene discussed is FAS; the disease is neoplasm.